BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6514303)

  • 1. Plasma timolol in glaucoma patients.
    Passo MS; Palmer EA; Van Buskirk EM
    Ophthalmology; 1984 Nov; 91(11):1361-3. PubMed ID: 6514303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients.
    Nieminen T; Uusitalo H; Turjanmaa V; Bjärnhall G; Hedenström H; Mäenpää J; Ropo A; Heikkilä P; Kähönen M
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):369-74. PubMed ID: 15912390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption of ocular timolol.
    Alvan G; Calissendorff B; Seideman P; Widmark K; Widmark G
    Clin Pharmacokinet; 1980; 5(1):95-100. PubMed ID: 7363532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of silicone punctal plugs as adjuncts to topical pharmacotherapy of glaucoma--a pilot study. Punctal Plugs in Glaucoma Study Group.
    Bartlett JD; Boan K; Corliss D; Gaddie IB
    J Am Optom Assoc; 1996 Nov; 67(11):664-8. PubMed ID: 8979659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical timolol and the nursing mother.
    Lustgarten JS; Podos SM
    Arch Ophthalmol; 1983 Sep; 101(9):1381-2. PubMed ID: 6615302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical timolol maleate might adversely affect serum lipoproteins.
    Safran AB; Simona F; Sansonetti A; Pometta D; James R
    Int Ophthalmol; 1993 Apr; 17(2):109-10. PubMed ID: 8407117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timolol and pediatric glaucomas.
    McMahon CD; Hetherington J; Hoskins HD; Shaffer RN
    Ophthalmology; 1981 Mar; 88(3):249-52. PubMed ID: 7231913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of latanoprost and timolol in pediatric glaucoma: a phase 3, 12-week, randomized, double-masked multicenter study.
    Maeda-Chubachi T; Chi-Burris K; Simons BD; Freedman SF; Khaw PT; Wirostko B; Yan E;
    Ophthalmology; 2011 Oct; 118(10):2014-21. PubMed ID: 21680022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timolol in childhood glaucoma.
    Boger WP
    Surv Ophthalmol; 1983 Dec; 28 Suppl():259-61. PubMed ID: 6665703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension.
    Dixon ER; Landry T; Venkataraman S; Gustafson N; Salem C; Bradfield Y; Aljasim LA; Feldman R
    J AAPOS; 2017 Oct; 21(5):370-374.e1. PubMed ID: 28887006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential side effects of timolol therapy in the treatment of glaucoma.
    Zimmerman TJ; Leader BJ; Golob DS
    Ann Ophthalmol; 1981 Jun; 13(6):683-9. PubMed ID: 7020551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical experiences with timolol eye drops].
    Ober M; Meythaler H; Porkert K
    Ophthalmologica; 1979; 178(4):204-9. PubMed ID: 481866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma.
    Dickstein K; Hapnes R; Aarsland T
    Am J Ophthalmol; 2001 Nov; 132(5):626-32. PubMed ID: 11704023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of timolol therapy on outflow facility.
    Sonntag JR; Brindley GO; Shields MB
    Invest Ophthalmol Vis Sci; 1978 Mar; 17(3):293-6. PubMed ID: 627467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma.
    Feldman RM; Stewart RH; Stewart WC; Jia G; Smugar SS; Galet VA
    Curr Med Res Opin; 2008 Aug; 24(8):2403-12. PubMed ID: 18627642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of ophthalmic timolol.
    Leier CV; Baker ND; Weber PA
    Ann Intern Med; 1986 Feb; 104(2):197-9. PubMed ID: 3946944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: a randomized clinical trial.
    Plager DA; Whitson JT; Netland PA; Vijaya L; Sathyan P; Sood D; Krishnadas SR; Robin AL; Gross RD; Scheib SA; Scott H; Dickerson JE;
    J AAPOS; 2009 Aug; 13(4):384-90. PubMed ID: 19683191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma.
    Boger WP; Puliafito CA; Steinert RF; Langston DP
    Ophthalmology; 1978 Mar; 85(3):259-67. PubMed ID: 351504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of severe bronchial asthma following first use of timolol ophthalmic solution].
    Inamizu T; Yoshikawa M; Murai H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Mar; 31(3):385-9. PubMed ID: 8315910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.